Having trouble accessing articles? Reset your cache.

Inecalcitol: Final Phase IIa data

Final data from an open-label, dose-escalation, French Phase IIa trial in 47 evaluable patients showed that 40 (85%) patients receiving up to

Read the full 222 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE